Fermenta Biotech (BOM:506414) E10: ₹15.07 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:506414 Fermenta Biotech Ltd BOM:506414
65 GF Score
Price ₹499.30
GF Value ₹321.75
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Fermenta Biotech E10?

Fermenta Biotech BOM:506414 +7.25% 65 E10 is ₹15.07 as of Mar. 2026. GuruFocus rates BOM:506414 with a GF Score™ of 65/100 and a GF Value™ of ₹321.75 (Significantly Overvalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Fermenta Biotech's adjusted earnings per share data for the three months ended in Mar. 2026 was ₹6.610. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹15.07 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Fermenta Biotech's average E10 Growth Rate was 22.70% per year. During the past 3 years, the average E10 Growth Rate was 13.60% per year. During the past 5 years, the average E10 Growth Rate was 3.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Fermenta Biotech was 13.60% per year. The lowest was -7.10% per year. And the median was 1.70% per year.

As of today (2026-08-01), Fermenta Biotech's current stock price is ₹499.30. Fermenta Biotech's E10 for the quarter that ended in Mar. 2026 was ₹15.07. Fermenta Biotech's Shiller PE Ratio of today is 33.13.

During the past 13 years, the highest Shiller PE Ratio of Fermenta Biotech was 41.40. The lowest was 10.40. And the median was 22.30.


Fermenta Biotech  (BOM:506414) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Fermenta Biotech's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=499.30/15.07
=33.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Fermenta Biotech was 41.40. The lowest was 10.40. And the median was 22.30.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Fermenta Biotech E10 Related Terms


Fermenta Biotech E10 Historical Data

* Premium members only.

The historical data trend for Fermenta Biotech's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fermenta Biotech E10 Chart

Fermenta Biotech Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.67 10.28 9.39 12.28 15.07

Fermenta Biotech Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.28 13.12 13.96 14.46 15.07

BOM:506414 vs ZTS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Fermenta Biotech's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fermenta Biotech Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fermenta Biotech's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Fermenta Biotech's Shiller PE Ratio falls into.


BOM:506414
65GF Score
Fermenta Biotech Ltd BOM:506414
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fermenta Biotech E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Fermenta Biotech's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=6.61/164.2724*164.2724
=6.610

Current CPI (Mar. 2026) = 164.2724.

Fermenta Biotech Quarterly Data

per share eps CPI Adj_EPS
201606 0.751 105.961 1.164
201609 -2.116 105.961 -3.280
201612 -1.581 105.196 -2.469
201703 -0.737 105.196 -1.151
201706 -0.366 107.109 -0.561
201709 1.280 109.021 1.929
201712 6.893 109.404 10.350
201803 6.511 109.786 9.742
201806 5.547 111.317 8.186
201809 11.960 115.142 17.063
201812 9.660 115.142 13.782
201903 13.330 118.202 18.525
201906 4.860 120.880 6.605
201909 11.310 123.175 15.084
201912 3.340 126.235 4.346
202003 1.060 124.705 1.396
202006 4.710 127.000 6.092
202009 5.090 130.118 6.426
202012 3.390 130.889 4.255
202103 2.530 131.771 3.154
202106 3.920 134.084 4.803
202109 1.560 135.847 1.886
202112 -2.790 138.161 -3.317
202203 2.650 138.822 3.136
202206 -0.900 142.347 -1.039
202209 -2.800 144.661 -3.180
202212 -12.660 145.763 -14.268
202303 -1.430 146.865 -1.599
202306 0.640 150.280 0.700
202309 -9.890 151.492 -10.724
202312 3.410 152.924 3.663
202403 -2.400 153.035 -2.576
202406 -2.010 155.789 -2.119
202409 3.940 157.882 4.099
202412 12.710 158.323 13.188
202503 11.790 157.552 12.293
202506 7.470 159.755 7.681
202509 6.430 162.289 6.509
202512 4.340 163.281 4.366
202603 6.610 164.272 6.610

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ₹15.07 mean?
Fermenta Biotech (BOM:506414) has a E10 of ₹15.07 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Fermenta Biotech and its competitors.
Is Fermenta Biotech's E10 too high?
Fermenta Biotech's current E10 is ₹15.07. Overall, Fermenta Biotech has a GF Score™ of 65/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Fermenta Biotech's E10 compare to ZTS?
Fermenta Biotech's E10 of ₹15.07 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Fermenta Biotech and its competitors. Fermenta Biotech's current E10 is ₹15.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fermenta Biotech stock overvalued right now?
Based on GuruFocus' analysis, Fermenta Biotech (BOM:506414) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹321.75, compared to a current price of ₹499.30 — trading 55.2% above its estimated fair value. The current E10 is ₹15.07. Fermenta Biotech's overall GF Score™ is 65/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Fermenta Biotech (BOM:506414), the current E10 is ₹15.07 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fermenta Biotech (BOM:506414) Overvalued in 2026?

Based on GuruFocus' analysis, Fermenta Biotech stock appears to be overvalued. The current stock price of ₹499.30 is trading 55.2% above its estimated GF Value™ of ₹321.75. GuruFocus considers Fermenta Biotech to be Significantly Overvalued.

Key valuation signals for BOM:506414:

  • E10: ₹15.07
  • GF Value™: ₹321.75 vs. price of ₹499.30 (55.2% above fair value)
  • GF Score™: 65/100 with 4 warning signs

No single metric tells the full story. See the BOM:506414 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Fermenta Biotech Business Description

Address Ghodbunder Road, A -1501, Thane One, DIL Complex, Majiwada, Thane (West), Thane, MH, IND, 400610
Fermenta Biotech Ltd is engaged in the business of manufacturing and marketing chemicals, bulk drugs, enzymes, pharmaceutical formulations, and environmental solution products and renting and selling properties. It is a manufacturer and supplier of Vitamin D and also supplies Penicillin G Amidase, CAL B Lipase, Polymer Supports, and enzyme technologies. The company operates in two segments namely Property and Bulk Drugs/Chemicals. The majority of the revenue comes from the Bulk Drug/Chemicals segment. Geographically, it caters to both domestic and international markets and generates maximum revenue from the Indian market.
65GF Score

Get the complete analysis for BOM:506414

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹499.30
Price
₹321.75
GF Value